Overview
![](/static/cov_static/images/index/index_epi.png)
Search Epitope
Mutations, conservation, receptors, cross-activity, experimental assays
![](/static/cov_static/images/index/index_ab.png)
Search Antibody
Binding and neutralizing viruses, binding sites, affinity, neutralization activity
![](/static/cov_static/images/index/index_var.png)
SARS-CoV-2 Variants
Resistance mutations, virological characteristics, in vitro activity
![](/static/cov_static/images/index/index_thera.png)
Therapeutics Summary
Vaccine, neutralizing antibody, convalescent plasma, in vitro activity
![](/static/cov_static/images/index/index_tool.png)
Epitope Prediction Pipeline
Interagted B-cell epitope and T-cell epitope prediction tools
News & Events
66210
Validated B epitopes
3209
Validated T epitopes
12613
Antibodies
988
Antibody structures
6641
Affinity Records
62916
Neutralizing Records
91
Virological characteristics
111
Therapeutics Records
10158
In vitro activity Records
237401
Predicted T epitopes
Records with information extracted from literature and computational analysis
Last updated on Nov 7, 2023
Framework
![](/static/cov_static/images/index/CovEpiAb_Framework.png)
Features
- Extensive epitope and antibody data, including more than 60 000 epitopes and 12 000 antibodies.
- Identification of HCoVs cross-reactive epitopes, and mutation and conservation annotation for epitopes and antibody binding sites.
- Over 69 000 experimental interaction data of antibody affinity and neutralizing activity.
- Virological characterization and more than 10 000 in vitro activity data of SARS-CoV-2 variants.
- Epitope prediction pipeline COVEP and HCoVs prediction results analysis.